RAPT Therapeutics Inc [RAPT] stock is trading at $1.74, up 110.81%. An important factor to consider is whether the stock is rising or falling in short-term value. The RAPT shares have gain 97.44% over the last week, with a monthly amount glided 65.71%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
RAPT Therapeutics Inc [NASDAQ: RAPT] stock has seen the most recent analyst activity on November 13, 2024, when Stifel downgraded its rating to a Hold and also revised its price target to $2 from $7. Previously, Piper Sandler downgraded its rating to Neutral on November 11, 2024, and dropped its price target to $2. On November 11, 2024, downgrade downgraded it’s rating to Underweight. Wolfe Research downgraded its rating to a Peer Perform. Guggenheim downgraded its rating to a Neutral. Barclays downgraded its rating to Equal Weight for this stock on May 10, 2024, and downed its price target to $4. In a note dated February 22, 2024, UBS downgraded an Neutral rating on this stock and revised its target price from $61 to $10.
RAPT Therapeutics Inc [RAPT] stock has fluctuated between $0.79 and $27.35 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. RAPT Therapeutics Inc [NASDAQ: RAPT] shares were valued at $1.74 at the most recent close of the market. An investor can expect a potential return of 14.94% based on the average RAPT price forecast.
Analyzing the RAPT fundamentals
Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -21.72%, Pretax Profit Margin comes in at -20.33%, and Net Profit Margin reading is -20.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.99, Equity is -0.89 and Total Capital is -1.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3600 points at the first support level, and at 0.9800 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.2200, and for the 2nd resistance point, it is at 2.7000.
Ratios To Look Out For
For context, RAPT Therapeutics Inc’s Current Ratio is 9.90. On the other hand, the Quick Ratio is 9.90, and the Cash Ratio is 3.66.
Transactions by insiders
Recent insider trading involved Brockstedt Dirk G., CHIEF SCIENTIFIC OFFICER, that happened on Jan 05 ’24 when 898.0 shares were sold.
